Marazban Sarkari

721 total citations
9 papers, 601 citations indexed

About

Marazban Sarkari is a scholar working on Pharmaceutical Science, Molecular Biology and Spectroscopy. According to data from OpenAlex, Marazban Sarkari has authored 9 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmaceutical Science, 3 papers in Molecular Biology and 3 papers in Spectroscopy. Recurrent topics in Marazban Sarkari's work include Drug Solubulity and Delivery Systems (4 papers), Analytical Chemistry and Chromatography (3 papers) and Phase Equilibria and Thermodynamics (3 papers). Marazban Sarkari is often cited by papers focused on Drug Solubulity and Delivery Systems (4 papers), Analytical Chemistry and Chromatography (3 papers) and Phase Equilibria and Thermodynamics (3 papers). Marazban Sarkari collaborates with scholars based in United States and India. Marazban Sarkari's co-authors include Keith P. Johnston, Robert O. Williams, Timothy J. Young, Xiaoxia Chen, Judith Brown, Barbara L. Knutson, Steve Swinnea, Andrew C. Nelsen, True L. Rogers and Jiahui Hu and has published in prestigious journals such as International Journal of Pharmaceutics, AIChE Journal and Pharmaceutical Research.

In The Last Decade

Marazban Sarkari

9 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marazban Sarkari United States 8 384 167 123 123 120 9 601
Michal E. Matteucci United States 8 438 1.1× 204 1.2× 104 0.8× 95 0.8× 96 0.8× 10 662
H Nyqvist Sweden 10 243 0.6× 131 0.8× 148 1.2× 99 0.8× 124 1.0× 32 576
Sandra Guns Belgium 5 410 1.1× 152 0.9× 97 0.8× 38 0.3× 154 1.3× 6 560
Shailesh V. Biradar India 10 250 0.7× 186 1.1× 49 0.4× 53 0.4× 114 0.9× 16 504
Eero Suihko Finland 12 278 0.7× 104 0.6× 55 0.4× 53 0.4× 114 0.9× 20 519
Judith Brown United States 4 298 0.8× 137 0.8× 87 0.7× 33 0.3× 104 0.9× 5 400
Scott V. Jermain United States 10 444 1.2× 225 1.3× 105 0.9× 41 0.3× 76 0.6× 10 596
John M. Baumann United States 12 217 0.6× 91 0.5× 90 0.7× 59 0.5× 140 1.2× 13 489
Chandra Vemavarapu United States 8 354 0.9× 208 1.2× 106 0.9× 110 0.9× 62 0.5× 8 565
Takehiko Yasuji Japan 10 254 0.7× 80 0.5× 44 0.4× 76 0.6× 68 0.6× 12 391

Countries citing papers authored by Marazban Sarkari

Since Specialization
Citations

This map shows the geographic impact of Marazban Sarkari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marazban Sarkari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marazban Sarkari more than expected).

Fields of papers citing papers by Marazban Sarkari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marazban Sarkari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marazban Sarkari. The network helps show where Marazban Sarkari may publish in the future.

Co-authorship network of co-authors of Marazban Sarkari

This figure shows the co-authorship network connecting the top 25 collaborators of Marazban Sarkari. A scholar is included among the top collaborators of Marazban Sarkari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marazban Sarkari. Marazban Sarkari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Melville, Chris R., et al.. (2017). Storage and transport of reconstituted omacetaxine mepesuccinate: Considerations for home administration. Journal of Oncology Pharmacy Practice. 24(3). 201–208. 1 indexed citations
2.
Chen, Xiaoxia, et al.. (2006). Ketoprofen nanoparticle gels formed by evaporative precipitation into aqueous solution. AIChE Journal. 52(7). 2428–2435. 14 indexed citations
3.
Sarkari, Marazban, et al.. (2003). CO 2 and Fluorinated Solvent‐Based Technologies for Protein Microparticle Precipitation from Aqueous Solutions. Biotechnology Progress. 19(2). 448–454. 27 indexed citations
4.
Rogers, True L., Andrew C. Nelsen, Marazban Sarkari, et al.. (2003). Enhanced Aqueous Dissolution of a Poorly Water Soluble Drug by Novel Particle Engineering Technology: Spray-Freezing into Liquid with Atmospheric Freeze-Drying. Pharmaceutical Research. 20(3). 485–493. 78 indexed citations
5.
Sarkari, Marazban, Judith Brown, Xiaoxia Chen, et al.. (2002). Enhanced drug dissolution using evaporative precipitation into aqueous solution. International Journal of Pharmaceutics. 243(1-2). 17–31. 158 indexed citations
6.
Chen, Xiaoxia, Timothy J. Young, Marazban Sarkari, Robert O. Williams, & Keith P. Johnston. (2002). Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution. International Journal of Pharmaceutics. 242(1-2). 3–14. 139 indexed citations
7.
Rogers, True L., Andrew C. Nelsen, Jiahui Hu, et al.. (2002). A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid. European Journal of Pharmaceutics and Biopharmaceutics. 54(3). 271–280. 107 indexed citations
8.
Sarkari, Marazban, et al.. (2000). Generation of microparticles using CO2 and CO2‐philic antisolvents. AIChE Journal. 46(9). 1850–1859. 68 indexed citations
9.
Sarkari, Marazban, Barbara L. Knutson, & Ching‐Shih Chen. (1999). Enzymatic catalysis in cosolvent modified pressurized organic solvents. Biotechnology and Bioengineering. 65(3). 258–264. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026